Zymergen Inc.

2022 Q3 Form 10-Q Financial Statement

#000164584222000114 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $213.6M $337.0M
YoY Change -63.04% 178.42%
Cash & Equivalents $213.6M $337.0M
Short-Term Investments
Other Short-Term Assets $1.469M $791.0K
YoY Change -30.38% -72.62%
Inventory $6.107M $5.995M
Prepaid Expenses $11.81M $5.764M
Receivables $3.696M $2.399M
Other Receivables $0.00 $0.00
Total Short-Term Assets $239.6M $353.6M
YoY Change -60.47% 153.07%
LONG-TERM ASSETS
Property, Plant & Equipment $70.59M $56.00M
YoY Change 13.02% 0.98%
Goodwill $0.00 $40.65M
YoY Change -100.0% 250.27%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.236M $2.187M
YoY Change -8.51% -86.33%
Total Long-Term Assets $231.3M $264.6M
YoY Change 93.91% 202.36%
TOTAL ASSETS
Total Short-Term Assets $239.6M $353.6M
Total Long-Term Assets $231.3M $264.6M
Total Assets $471.0M $618.2M
YoY Change -35.08% 172.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.88M $6.371M
YoY Change -9.57% -61.57%
Accrued Expenses $27.01M $21.38M
YoY Change -18.43% 2.11%
Deferred Revenue $4.410M $2.862M
YoY Change 30.24% 36.16%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $50.56M
YoY Change
Total Short-Term Liabilities $52.20M $88.46M
YoY Change 0.81% 119.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $3.968M $4.496M
YoY Change 34.55% 71.34%
Total Long-Term Liabilities $3.968M $4.496M
YoY Change -95.21% -94.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.20M $88.46M
Total Long-Term Liabilities $3.968M $4.496M
Total Liabilities $234.3M $274.1M
YoY Change 50.12% 86.02%
SHAREHOLDERS EQUITY
Retained Earnings -$1.300B -$1.200B
YoY Change 35.53% 39.81%
Common Stock $104.0K $103.0K
YoY Change 0.97% 692.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $236.6M $344.1M
YoY Change
Total Liabilities & Shareholders Equity $471.0M $618.2M
YoY Change -35.08% 172.05%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001645842
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201602Member
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40354
dei Entity Registrant Name
EntityRegistrantName
Zymergen Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2942439
dei Entity Address Address Line1
EntityAddressAddressLine1
5959 Horton Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Emeryville
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94608
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
801-8073
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
ZY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
104098538 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213558000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
386105000 usd
CY2022Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1272000 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
520000 usd
CY2022Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2424000 usd
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2565000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11814000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7818000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
6107000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6035000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
2997000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2105000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1469000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2201000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
239641000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
407349000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
10016000 usd
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
9849000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70590000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53799000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
141105000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
0 usd
CY2021Q4 us-gaap Goodwill
Goodwill
40645000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7380000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8529000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2236000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2225000 usd
CY2022Q2 us-gaap Assets
Assets
470968000 usd
CY2021Q4 us-gaap Assets
Assets
522396000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
12877000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5418000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27009000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17496000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7900000 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
43953000 usd
CY2022Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
0 usd
CY2021Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
2218000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4410000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4468000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
52196000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73553000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
178181000 usd
CY2022Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
0 usd
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
35390000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3968000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4967000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
234345000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
113910000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
170000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
170000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103828096 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103828096 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103045299 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103045299 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
104000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
103000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1560628000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1543908000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1324109000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1135525000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
236623000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
408486000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
470968000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
522396000 usd
CY2022Q2 us-gaap Revenues
Revenues
2634000 usd
CY2021Q2 us-gaap Revenues
Revenues
5854000 usd
us-gaap Revenues
Revenues
7425000 usd
us-gaap Revenues
Revenues
9589000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31186000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50152000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
59925000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89963000 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3158000 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7904000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6796000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14776000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24294000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23661000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47999000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42992000 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
40645000 usd
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
40645000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
55000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q2 zy Restructuring Charges Benefit
RestructuringChargesBenefit
-185000 usd
CY2021Q2 zy Restructuring Charges Benefit
RestructuringChargesBenefit
0 usd
zy Restructuring Charges Benefit
RestructuringChargesBenefit
-315000 usd
zy Restructuring Charges Benefit
RestructuringChargesBenefit
0 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
108830000 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
103546000 usd
us-gaap Costs And Expenses
CostsAndExpenses
177237000 usd
us-gaap Costs And Expenses
CostsAndExpenses
190690000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-106196000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-97692000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-169812000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-181101000 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
12000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
53000 usd
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
430000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
9378000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
2767000 usd
us-gaap Interest Expense
InterestExpense
17423000 usd
us-gaap Interest Expense
InterestExpense
5494000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1849000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-885000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1417000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-768000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10261000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3190000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18787000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4358000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.30
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-116457000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-100882000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-188599000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-185459000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-116468000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-116468000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-100866000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-100866000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-188584000 usd
us-gaap Net Income Loss
NetIncomeLoss
-188584000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-185451000 usd
us-gaap Net Income Loss
NetIncomeLoss
-185451000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.10
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103482907 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77671643 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103297070 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45512654 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103482907 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77671643 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103297070 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45727153 shares
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
408486000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
303000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7391000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-72116000 usd
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
344064000 usd
CY2022Q2 zy Stock Issued During Period Value Restricted Stock Units
StockIssuedDuringPeriodValueRestrictedStockUnits
0 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8642000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
385000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-116468000 usd
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
236623000 usd
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
68093280 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
900798000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-743736000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3189000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2253000 usd
CY2021Q1 zy Adjustments To Additional Paid In Capital Cash Settlement For Loan
AdjustmentsToAdditionalPaidInCapitalCashSettlementForLoan
1946000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-84585000 usd
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
68093280 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
900798000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-820933000 usd
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
45138000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
529897000 usd
CY2021Q2 zy Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
883332 shares
CY2021Q2 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
27384000 usd
CY2021Q2 zy Reclassifications Of Temporary To Permanent Equity Shares
ReclassificationsOfTemporaryToPermanentEquityShares
68976612 shares
CY2021Q2 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
-928182000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
928182000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
24809000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1258000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6965000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-100866000 usd
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
569312000 usd
us-gaap Net Income Loss
NetIncomeLoss
-188584000 usd
us-gaap Net Income Loss
NetIncomeLoss
-185451000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10209000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9330000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
16033000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9218000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5930000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 usd
zy Noncash Interest Expense
NoncashInterestExpense
14532000 usd
zy Noncash Interest Expense
NoncashInterestExpense
580000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
40645000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1849000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1290000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-573000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
111000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
35000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
752000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3482000 usd
zy Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
-141000 usd
zy Increase Decrease In Unbilled Receivables Current
IncreaseDecreaseInUnbilledReceivablesCurrent
-192000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5732000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6718000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
72000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
982000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-732000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-430000 usd
zy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-2677000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-38000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1076000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2821000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2825000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1879000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1015000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-87000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
605000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
zy Increase Decrease Deferred Rent Credit
IncreaseDecreaseDeferredRentCredit
0 usd
zy Increase Decrease Deferred Rent Credit
IncreaseDecreaseDeferredRentCredit
11943000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-42000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
173000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99575000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-167104000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13068000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19563000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
209000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
0 usd
us-gaap Cash Acquired In Excess Of Payments To Acquire Business
CashAcquiredInExcessOfPaymentsToAcquireBusiness
1238000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12859000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18325000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
533293000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
15002000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
303000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4448000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
385000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213558000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
58485000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1946000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-49000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-57846000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
554689000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1208000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-532000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-171488000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
368728000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
398059000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
219810000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
226571000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588538000 usd
us-gaap Stock Issued1
StockIssued1
24809000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
17550000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5675000 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
577731000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
2997000 usd
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
30000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
10016000 usd
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
10777000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
226571000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588538000 usd
us-gaap Interest Paid Net
InterestPaidNet
2891000 usd
us-gaap Interest Paid Net
InterestPaidNet
4942000 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
928182000 usd
zy Warrant Exercised
WarrantExercised
0 usd
zy Warrant Exercised
WarrantExercised
12382000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
749000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on December 31. References to fiscal 2022, for example, refer to the fiscal year ended December 31, 2022. The period end for the Company covered by this report is June 30, 2022.</span></div>
zy Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet
-4112000 usd
zy Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNet
0 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
2948000 usd
zy Stock Settled
StockSettled
0 usd
zy Stock Settled
StockSettled
1946000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1300000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-188600000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99600000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213600000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presentation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates include, but are not limited to, standalone selling price of performance obligations for contracts with multiple performance obligations, estimate of variable consideration from revenue contracts, useful life of property and equipment, fair value of the reporting unit for purposes of the assessment of goodwill impairment and undiscounted cash flows and residual values of long-lived assets of which the carrying value may not be recoverable, allowance for doubtful accounts, net realizable value of inventories, the valuation of intangible assets, the valuation of common and preferred stock used in the valuation of options to purchase common stock and warrants to purchase common stock or preferred stock, prior to being a publicly traded company, and the incremental borrowing rate used in determining operating lease liabilities. Actual results could differ from those estimates.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2022Q2 zy Social Security Tax Employer Deferral Cares Act
SocialSecurityTaxEmployerDeferralCARESAct
1800000 usd
CY2021Q4 zy Social Security Tax Employer Deferral Cares Act
SocialSecurityTaxEmployerDeferralCARESAct
3700000 usd
CY2022Q2 zy Social Security Tax Employer Deferral Cares Act
SocialSecurityTaxEmployerDeferralCARESAct
1800000 usd
CY2021Q4 us-gaap Restructuring And Related Cost Expected Cost Remaining1
RestructuringAndRelatedCostExpectedCostRemaining1
0 usd
CY2022Q2 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
28500000 usd
CY2022Q2 zy Restructuring And Related Cost Cash Outlays Expected Cost
RestructuringAndRelatedCostCashOutlaysExpectedCost
16700000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
15300000 usd
CY2022Q2 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
28500000 usd
CY2022Q2 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
28493000 usd
CY2022Q2 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
28493000 usd
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
2398000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Depreciation
Depreciation
9100000 usd
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-315000 usd
zy Proceed Payments For Restructuring
ProceedPaymentsForRestructuring
-754000 usd
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
1329000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
0 usd
CY2021Q4 us-gaap Goodwill
Goodwill
40645000 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
40600000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13700000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13700000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6320000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5171000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7380000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8529000 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1099000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2067000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1271000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1271000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1271000 usd
CY2022Q2 zy Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
401000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7380000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
82784000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78132000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70590000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53799000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
4200000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
4400000 usd
us-gaap Depreciation
Depreciation
8500000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9089000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6027000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13317000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7045000 usd
CY2022Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1329000 usd
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
2398000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3206000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1940000 usd
CY2022Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
68000 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
86000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27009000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17496000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
6107000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6035000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
43953000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 usd
CY2022Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1453000 usd
CY2021Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2471000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2891000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4914000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4669000 usd
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
296000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8310000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
580000 usd
CY2022Q2 us-gaap Accretion Expense
AccretionExpense
3256000 usd
CY2021Q2 us-gaap Accretion Expense
AccretionExpense
0 usd
us-gaap Accretion Expense
AccretionExpense
6222000 usd
us-gaap Accretion Expense
AccretionExpense
0 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
9378000 usd
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2767000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
17423000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
5494000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
8628000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
17437000 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
1687000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
3306000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
172000 usd
us-gaap Sublease Income
SubleaseIncome
344000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
10143000 usd
us-gaap Lease Cost
LeaseCost
20399000 usd
CY2021Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
9500000 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
15800000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
6872000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
11219000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y5M4D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1260
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
15717000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
30256000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
30661000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
30253000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
31091000 usd
CY2022Q2 zy Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
208242000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
346220000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
160139000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
186081000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
343000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
686000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
686000 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
114000 usd
CY2022Q2 zy Lessor Operating Lease Payment To Be Received After Year Three
LessorOperatingLeasePaymentToBeReceivedAfterYearThree
0 usd
CY2022Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1829000 usd
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
26387000 usd
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
30450000 usd
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
30630000 usd
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
29459000 usd
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
30350000 usd
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
206587000 usd
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
353863000 usd
CY2022Q2 zy Share Based Payment Arrangement Number Of Stock Based Compensation Plans
ShareBasedPaymentArrangementNumberOfStockBasedCompensationPlans
3 stock_based_compensation_plan
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0077
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0109
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7303
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7467
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
29600000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8642000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6965000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16033000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9218000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8642000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6965000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16033000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9218000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-116468000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100866000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-188584000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-185451000 usd
CY2022Q2 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2021Q2 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-1849000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-116468000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-100866000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-188584000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-187300000 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103482907 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77671643 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103297070 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45512654 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
214499 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103482907 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77671643 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103297070 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45727153 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.13
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.83
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.07
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.13
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.10
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14672694 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6586384 shares
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
8195000 usd
zy Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1260000 usd
zy Contract With Customer Liability Adjustments
ContractWithCustomerLiabilityAdjustments
0 usd
zy Contract With Customer Liability Deletions
ContractWithCustomerLiabilityDeletions
3586000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5869000 usd
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3014000 usd
zy Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
7057000 usd
zy Contract With Customer Liability Adjustments
ContractWithCustomerLiabilityAdjustments
6819000 usd
zy Contract With Customer Liability Deletions
ContractWithCustomerLiabilityDeletions
5764000 usd
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11126000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5108000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4099000 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
9207000 usd
CY2021Q4 zy Revenues Maximum Potential Grant Revenue To Be Awarded
RevenuesMaximumPotentialGrantRevenueToBeAwarded
2900000 usd
CY2022Q2 us-gaap Deferred Income
DeferredIncome
2300000 usd
CY2022Q2 us-gaap Revenues
Revenues
2634000 usd
CY2021Q2 us-gaap Revenues
Revenues
5854000 usd
us-gaap Revenues
Revenues
7425000 usd
us-gaap Revenues
Revenues
9589000 usd

Files In Submission

Name View Source Status
0001645842-22-000114-index-headers.html Edgar Link pending
0001645842-22-000114-index.html Edgar Link pending
0001645842-22-000114.txt Edgar Link pending
0001645842-22-000114-xbrl.zip Edgar Link pending
exhibit1012022q2.htm Edgar Link pending
exhibit3112022q2.htm Edgar Link pending
exhibit3122022q2.htm Edgar Link pending
exhibit3212022q2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zy-20220630.htm Edgar Link pending
zy-20220630.xsd Edgar Link pending
zy-20220630_def.xml Edgar Link unprocessable
zy-20220630_lab.xml Edgar Link unprocessable
zy-20220630_htm.xml Edgar Link completed
zy-20220630_pre.xml Edgar Link unprocessable
zy-20220630_cal.xml Edgar Link unprocessable